In this issue:
Progression to type 2 diabetes after GDM
CGM in adolescents/young adults and the elderly with type 1 diabetes
Adding apabetalone to standard therapy in type 2 diabetes with acute coronary syndrome
Preoperative metformin and postoperative outcomes in type 2 diabetes
Serum urate level lowering with allopurinol and kidney function in type 1 diabetes
Risk of CV events and death after starting SGLT-2 inhibitors vs. DPP-4 inhibitors
Oral semaglutide in type 2 diabetes (PIONEER 9 & 10)
Liraglutide in overweight/obese type 2 diabetics receiving basal insulin
Please login below to download this issue (PDF)